A system biology approach reveals cellular pathway differences between follicular thyroid carcinoma and follicular thyroid adenoma
Preprint
Abstract
Pathogenic mechanisms that underlie malignant follicular thyroid carcinoma (FTC) development are poorly understood. To identify key genes and pathways driving malignant behaviour we employed a system biology-based integrative analyses comparing FTC transcriptomes with a similar but benign lesion, follicular thyroid adenoma (FTA). We identified differentially expressed genes (DEGs) in microarray gene expression datasets (n=52) of FTCs and FTA tissues. Pathway analyses of DEGs using gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) resources revealed significant pathways, and pathway hub genes using protein-protein interactions (PPI). We identified 598 DEGs (relative to FTAs) in FTCs and 12 significant pathways with altered expression in FTC. 10 GO groups were significantly connected with FTC-high expression DEGs and 80 with low-FTC expression. PPI analysis identified 12 potential hub genes based on degree and betweenness centrality. Moreover, 10 transcription factors (TFs) were identified that may underlie DEG expression as well as a number of microRNA (miRNAs). Thus, we identified DEGs, pathways, TFs and miRNAs that reflect molecular mechanisms differing between FTC and benign FTA. These may constitute biomarkers that distinguish these lesions and, given the similarities and common origin of the lesions, they may also be indicators of malignant progression potential.Keywords
This publication has 52 references indexed in Scilit:
- A Network-Based Approach to Identify Molecular Signatures and Comorbidities of Thyroid Cancer2019
- Identification of Ovarian Cancer Gene Expression Patterns Associated with Disease Progression and MortalitybioRxiv, 2018
- Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancerOncotarget, 2017
- Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical AnalysisInternational Journal of Molecular Sciences, 2017
- Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERTOncotarget, 2016
- Expression of YY1 in Differentiated Thyroid CancerEndocrine Pathology, 2015
- Key genes and pathways in thyroid cancer based on gene set enrichment analysisOncology Reports, 2013
- Differential regulation of mitogen-activated protein kinase signaling pathways in human with different types of mitral valvular diseaseJournal of Surgical Research, 2012
- MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancerOncogene, 2011
- NCBI GEO: mining tens of millions of expression profiles--database and tools updateNucleic Acids Research, 2006